THOMPSON V. WESTERN STATES MEDICAL CENTER
535 U.S. 357 (2002)
NATURE OF THE CASE: Thompson (D) appealed an affirmation by the Ninth Circuit of the
District Court's holding for Western (P) in P's suit to enjoin enforcement of advertising
and solicitation provisions in the FDAMA.
FACTS: Under the FDAMA a compound prescription must be 'unsolicited,' 353a(a), and the
pharmacy, licensed pharmacist, or licensed physician compounding the drug may 'not advertise
or promote the compounding of any particular drug, class of drug, or type of drug.'
353a(c). The pharmacy, licensed pharmacist, or licensed physician may, however, 'advertise
and promote the compounding service.' Ps are a group of licensed pharmacies that specialize
in drug compounding. They have prepared promotional materials that they distribute by mail
and at medical conferences to inform patients and physicians of the use and effectiveness of
specific compounded drugs. Ps sued D under a violation of the Free Speech Clause of the
First Amendment. The District Court granted summary judgment to P, finding unconstitutional
restrictions on commercial speech under Central Hudson. The Court severed the solicitation
provisions from the rest of 503A of the FDAMA, 21 U. S. C. 353a, and left the Act's other
compounding requirements intact. D appealed. The Court of Appeals agreed that the FDAMA's
advertisement and solicitation restrictions fail Central Hudson's test for permissible
regulation of commercial speech. D had not demonstrated that the speech restrictions would
directly advance its interests or that alternatives less restrictive of speech were
unavailable. The Court of Appeals disagreed, over severability. The Court of Appeals
invalidated 503A in its entirety. The Supreme Court granted certiorari.
ISSUE:
RULE OF LAW:
HOLDING AND DECISION:
LEGAL ANALYSIS:
Get
free access to the entire content for Mac, PC or Online
for 2-3 days and free samples
of all kinds of products.
for 2-3 days and free samples of all kinds of products.
https://bsmsphd.com
© 2007-2016 Abn Study Partner
No comments:
Post a Comment